menu
At Sanalife, we believe it's imperative to offer our customers solutions that improve indoor environments that promote health and wellness. ActivePure® is the leading purification technology to reduce harmful contaminants in the air and on surfaces. The technology has a proven track record and is supported by exhaustive testing in FDA-Compliant and third-party laboratories. The FDA reviewed the testing results listed below as part of the Class II Medical Device Clearance process, unless otherwise noted.*
*The application of ActivePure® should complement existing regulatory guidelines for sanitization and disinfection and not replace them.
Testing of the SARS-CoV-2 virus was completed in August 2020 (surface) and in December 2020 (airborne). The results of the laboratory testing revealed extraordinary reduction levels of the virus that causes COVID-19.
The Aerus Pure & Clean is scientifically proven to reduce over 99.96% of airborne SARS-CoV-2 viral particles (the virus that causes COVID-19).* Laboratory testing showed a dramatic airborne reduction of the virus within 3 minutes. The testing of the SARS-CoV-2 viral reduction was conducted in FDA-Compliant laboratories against the live SARS-CoV-2 virus (not proxy or surrogate strains).
*Results are based on testing conducted at UTMB BSL Level 3 Lab with assistance from BSL Level 4 Lab, complying with FDA protocols in a FDA Certified Compliant Laboratory (Aerus Pure & Clean).
The Aerus Hydroxyl Blaster is scientifically proven to reduce over 99.98% of SARS-CoV-2 viral particles (the virus that causes COVID-19) on surfaces.* Laboratory testing showed a dramatic surface reduction of the virus within 7 hours. The testing of the SARS-CoV-2 viral reduction was conducted in FDA-Compliant laboratories against the live SARS-CoV-2 virus (not proxy or surrogate strains).
*Results are based on testing conducted at MRIGlobal, an independent, FDA-Compliant laboratory. The reduction percentages were measured incrementally over natural degradation of SARS-CoV-2. Outside of control group - over 99.9% reduction of the SARS-CoV-2 virus (Aerus Hydroxyl Blaster).
Results are based on laboratory testing conducted to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. Field results may vary based on environmental conditions. These results have not been evaluated by the FDA.
Results are based on testing conducted at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction of MS2 Bacteriophage Virus Bioaerosol (Aerus Medical Guardian).
Results are based on testing conducted at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction Phi-X174 of Bacteriophage Virus Bioaerosol (Aerus Medical Guardian).
Results are based on laboratory testing conducted to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. Field results may vary based on environmental conditions. These results have not been evaluated by the FDA.
Results are based on testing conducted at Danish Technological Institute. Testing was completed with the air purifier installed within a seal 20 cubic meter room. Experiment was designed to measure the reduction rate during the use of the Beyond Guardian.
Results are based on testing conducted at Danish Technological Institute. Testing was completed with the air purifier installed within a seal 20 cubic meter room. Experiment was designed to measure the reduction rate during the use of the Beyond Guardian.
Results are based on testing conducted at Danish Technological Institute. Testing was completed with the air purifier installed within a seal 20 cubic meter room. Experiment was designed to measure the reduction rate during the use of the Beyond Guardian.
Results are based on testing conducted using ActivePure® Technology within a Hotel Facility. The results are combined from testing conducted within 3 rooms.
Results are based on testing conducted using ActivePure® Technology within a Hotel Facility. The results are combined from testing conducted within 3 rooms.
Results are based on testing conducted in Eastern Health Canada Medical Surgical & Cardio ICU settings to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. These results have not been evaluated by the FDA.
Results are based on testing conducted in Eastern Health Canada Medical Surgical & Cardio ICU settings to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. These results have not been evaluated by the FDA.
Results are based on testing conducted in Eastern Health Canada Medical Surgical & Cardio ICU settings to demonstrate the use of ActivePure® Technology in substantially reducing airborne contaminants. These results have not been evaluated by the FDA.
ActivePure® Technology is an active purification technology that puts back into the air the same therapeutic molecules that make our outdoor air safe – molecules that actively neutralize pathogens and volatile organic compounds (VOCs) as they enter the space. ActivePure® provides a layer of protection that reduces airborne and surface pathogens quickly and effectively.
